# Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

> **NCT01038895** · PHASE4 · UNKNOWN · sponsor: **University of Pavia** · enrollment: 120 (estimated)

## Conditions studied

- Hypertension
- Type 2 Diabetes

## Interventions

- **DRUG:** Ramipril
- **DRUG:** Experimental

## Key facts

- **NCT ID:** NCT01038895
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** 2011-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2009-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038895, "Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01038895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*